Fatcow Icon
Wilder named Group Revenue Director for SC newspapers
Don Wilder
Don Wilder
slideshow

NEWBERRY — Donald E. (Don) Wilder has been named the new Customer Relations Manager and Group Revenue Director of the South Carolina Group of Civitas Media’s publications in South Carolina.

The South Carolina Group includes The Newberry Observer in Newberry, The Herald Independent in Winnsboro, The Union Daily Times, The Easley Progress, The Pickens Sentinel and the Powdersville Post. He also will serve as the General Manager of the Newberry facility. Wilder replaces David Emmons who has returned to Florida to spend more time with his family.

Wilder was named to his new position by Joe Craig, Civitas Media’s Chief Revenue Officer.

“We are very pleased to be able to appoint a Sales Manager for our South Carolina newspapers with the enthusiasm and skills of Don Wilder,” Craig said. “Don is someone who has a history of deep involvement with the communities in which he serves as well as a track record of producing successful and improved newspaper products.”

Wilder, a longtime resident of the Upstate, has published newspapers in Union, and most recently as Chief Executive Officer of Hometown News Co., a group of newspapers in Spartanburg, Cherokee and Newberry counties.

“I am excited to become a part of Civitas Media and the opportunities and challenges that lie ahead,” said Wilder. “It is especially gratifying to me to be able to return and work once again with the businesses and people I have grown to know and respect over the tenure of my career.”

Wilder served as publisher of The Union Daily Times from 1972 to 1995 when he was transferred as publisher to The Williamson Daily News in Williamson, W.Va. He left Williamson in 1996 to take over the management of Hometown News Co. in Spartanburg.

Wilder is a former president of the Union Chamber of Commerce, organizing president of the Union Kiwanis Club, and recipient of the Union Jaycee Chapter “Outstanding Citizen of the Year” award. The Union Vocational School also recognized him as “Advisor of the Year.”

At the state level, Wilder served as Highway Commissioner of the then 4th Congressional District consisting of Union and York counties and was the first chairman of the Union Highway Committee. He is the recipient of “The Order of The Palmetto,” South Carolina’s highest citizen award.

During his newspaper career, Wilder has served twice on the Executive Committee of the S.C. Press Association, and once on the Executive Committee of the West Virginia Press Association. While in Williamson, Wilder was appointed to and served on the Williamson Memorial Hospital board of directors.

Most recently Wilder, served as president of the Daniel Morgan Chapter of the Sons of the American Revolution in Spartanburg.

He is married to the former Joyce Toler, and they have one daughter Shayna, wife of Steve Blackwell, publisher of The Greer Citizen, and one granddaughter Sagen Blackwell, 20, a graduate of Converse College pursuing her master’s degree at Liberty University in Lynchburg, Va.

Share This Article |
similar stories

Mr. Tommie Madison Hinton | 8 days ago

Learning SC history | 27 days ago

Palmetto names new athletic director, football coach | 28 days ago by Billy Cannada
Staff Writer

COMMUNITY CALENDAR | 17 days ago

Elmon J. Estes, Jr. | 20 days ago

Comments
(0)
Comments-icon Post a Comment
No Comments Yet
Photo contest deadline is Friday
COLUMBIA — The deadline is Feb. 15 for the S.C. Department of Commerce’s ninth annual Rural Summi...
Feb 12, 2013 | 0 0 comments | 55 55 recommendations | email to a friend
full story
Newberry Opera House to host John Michael Montgomery
NEWBERRY — John Michael Montgomery, a Kentucky-born artist whose personal contributions to the st...
Feb 05, 2013 | 0 0 comments | 55 55 recommendations | email to a friend
full story

News
ID02_18218308_web.jpg
slideshow
E470_17642865_web.jpg
slideshow
FHHB_18227527_web.jpg
slideshow
CUO9_1630484_web.jpg
slideshow
More Americans choosing generic drugs
by Brandpoint (ARA) Sponsored Content
Jun 19, 2013 | 154 views | 0 0 comments | 22 22 recommendations | email to a friend | print
(BPT) - Have you ever gone to fill a prescription and the pharmacist asks if you’d like the generic version of the medication, perhaps reminding you that it is at a considerable cost savings over the brand-named drug? Or you’re told that your insurance will only cover the generic equivalent of what your doctor has prescribed?
The first time this happens, you undoubtedly have many questions: Is there a difference between branded and generic medicines? Will the generic be just as safe and effective? Do insurance companies prefer generics? If you have, you’re not alone in asking these questions.
 It’s no secret that the rising costs of health care services and medications have been affecting millions of Americans – indeed, our economy – and will undoubtedly continue to do so in the future. However, generic alternatives have proven to be a critical factor in slowing down national health care spending. In fact, generic drug use has saved America’s health care system approximately $1.07 trillion over the past decade, with $192.8 billion in savings achieved in 2011 alone, according to a 2012 study by the IMS Institute for Healthcare Informatics.
However, while consumers recognize the cost advantage of generic drugs, they are reminded, from time to time, of the question of quality and efficacy of generic medications versus name-brand equivalents. Consumers should know that the U.S. Food and Drug Administration, the federal agency responsible for protecting and promoting public health, requires that generic drugs must be identical or “bioequivalent” to brand name drugs in dosage form, safety, strength, route of administration, quality, performance characteristics and intended use.
“The U.S. FDA tests generic medicines just as rigorously as their branded counterparts,” explains Venkat Krishnan, senior vice president and regional director at Ranbaxy Inc. “Generic drugs must meet rigid qualifying criteria before they can be made available to the general public. At Ranbaxy, we have stringent protocols in place to ensure that our products are both safe and effective, and we stand behind that, focused on our philosophy of ‘Quality and Patients First.’”
People are choosing generics in increasing numbers, out of economic necessity and because they are increasingly better informed.Of the 4 billion prescriptions written in 2011, nearly 80 percent were dispensed using generic versions of their brand name counterpart. With generics, consumers have the option of paying a price that is as much as 85 percent lower than name-brand drugs.
If you have questions about switching to a generic prescription, have a conversation with your doctor or pharmacist, or visit www.gphaonline.org for more information and the facts about generic drugs.
Share This Free article |
Comments
(0)
Comments-icon Post a Comment
No Comments Yet
Read More News
Sports
ID02_18218308_web.jpg
slideshow
E470_17642865_web.jpg
slideshow
FHHB_18227527_web.jpg
slideshow
CUO9_1630484_web.jpg
slideshow
More Americans choosing generic drugs
by Brandpoint (ARA) Sponsored Content
Jun 19, 2013 | 154 views | 0 0 comments | 22 22 recommendations | email to a friend | print
(BPT) - Have you ever gone to fill a prescription and the pharmacist asks if you’d like the generic version of the medication, perhaps reminding you that it is at a considerable cost savings over the brand-named drug? Or you’re told that your insurance will only cover the generic equivalent of what your doctor has prescribed?
The first time this happens, you undoubtedly have many questions: Is there a difference between branded and generic medicines? Will the generic be just as safe and effective? Do insurance companies prefer generics? If you have, you’re not alone in asking these questions.
 It’s no secret that the rising costs of health care services and medications have been affecting millions of Americans – indeed, our economy – and will undoubtedly continue to do so in the future. However, generic alternatives have proven to be a critical factor in slowing down national health care spending. In fact, generic drug use has saved America’s health care system approximately $1.07 trillion over the past decade, with $192.8 billion in savings achieved in 2011 alone, according to a 2012 study by the IMS Institute for Healthcare Informatics.
However, while consumers recognize the cost advantage of generic drugs, they are reminded, from time to time, of the question of quality and efficacy of generic medications versus name-brand equivalents. Consumers should know that the U.S. Food and Drug Administration, the federal agency responsible for protecting and promoting public health, requires that generic drugs must be identical or “bioequivalent” to brand name drugs in dosage form, safety, strength, route of administration, quality, performance characteristics and intended use.
“The U.S. FDA tests generic medicines just as rigorously as their branded counterparts,” explains Venkat Krishnan, senior vice president and regional director at Ranbaxy Inc. “Generic drugs must meet rigid qualifying criteria before they can be made available to the general public. At Ranbaxy, we have stringent protocols in place to ensure that our products are both safe and effective, and we stand behind that, focused on our philosophy of ‘Quality and Patients First.’”
People are choosing generics in increasing numbers, out of economic necessity and because they are increasingly better informed.Of the 4 billion prescriptions written in 2011, nearly 80 percent were dispensed using generic versions of their brand name counterpart. With generics, consumers have the option of paying a price that is as much as 85 percent lower than name-brand drugs.
If you have questions about switching to a generic prescription, have a conversation with your doctor or pharmacist, or visit www.gphaonline.org for more information and the facts about generic drugs.
Share This Free article |
Comments
(0)
Comments-icon Post a Comment
No Comments Yet
Read More Sports
Opinion
ID02_18218308_web.jpg
slideshow
E470_17642865_web.jpg
slideshow
FHHB_18227527_web.jpg
slideshow
CUO9_1630484_web.jpg
slideshow
More Americans choosing generic drugs
by Brandpoint (ARA) Sponsored Content
Jun 19, 2013 | 154 views | 0 0 comments | 22 22 recommendations | email to a friend | print
(BPT) - Have you ever gone to fill a prescription and the pharmacist asks if you’d like the generic version of the medication, perhaps reminding you that it is at a considerable cost savings over the brand-named drug? Or you’re told that your insurance will only cover the generic equivalent of what your doctor has prescribed?
The first time this happens, you undoubtedly have many questions: Is there a difference between branded and generic medicines? Will the generic be just as safe and effective? Do insurance companies prefer generics? If you have, you’re not alone in asking these questions.
 It’s no secret that the rising costs of health care services and medications have been affecting millions of Americans – indeed, our economy – and will undoubtedly continue to do so in the future. However, generic alternatives have proven to be a critical factor in slowing down national health care spending. In fact, generic drug use has saved America’s health care system approximately $1.07 trillion over the past decade, with $192.8 billion in savings achieved in 2011 alone, according to a 2012 study by the IMS Institute for Healthcare Informatics.
However, while consumers recognize the cost advantage of generic drugs, they are reminded, from time to time, of the question of quality and efficacy of generic medications versus name-brand equivalents. Consumers should know that the U.S. Food and Drug Administration, the federal agency responsible for protecting and promoting public health, requires that generic drugs must be identical or “bioequivalent” to brand name drugs in dosage form, safety, strength, route of administration, quality, performance characteristics and intended use.
“The U.S. FDA tests generic medicines just as rigorously as their branded counterparts,” explains Venkat Krishnan, senior vice president and regional director at Ranbaxy Inc. “Generic drugs must meet rigid qualifying criteria before they can be made available to the general public. At Ranbaxy, we have stringent protocols in place to ensure that our products are both safe and effective, and we stand behind that, focused on our philosophy of ‘Quality and Patients First.’”
People are choosing generics in increasing numbers, out of economic necessity and because they are increasingly better informed.Of the 4 billion prescriptions written in 2011, nearly 80 percent were dispensed using generic versions of their brand name counterpart. With generics, consumers have the option of paying a price that is as much as 85 percent lower than name-brand drugs.
If you have questions about switching to a generic prescription, have a conversation with your doctor or pharmacist, or visit www.gphaonline.org for more information and the facts about generic drugs.
Share This Free article |
Comments
(0)
Comments-icon Post a Comment
No Comments Yet
Read More Opinion
Latest Video
Weather
Sponsored By:

RSS Feeds
All articles feed
News feed
Sports feed
Videos feed
Obituaries feed
Opinion feed
Local Features
ID02_18218308_web.jpg
slideshow
E470_17642865_web.jpg
slideshow
FHHB_18227527_web.jpg
slideshow
CUO9_1630484_web.jpg
slideshow
More Americans choosing generic drugs
by Brandpoint (ARA) Sponsored Content
Jun 19, 2013 | 154 views | 0 0 comments | 22 22 recommendations | email to a friend | print
(BPT) - Have you ever gone to fill a prescription and the pharmacist asks if you’d like the generic version of the medication, perhaps reminding you that it is at a considerable cost savings over the brand-named drug? Or you’re told that your insurance will only cover the generic equivalent of what your doctor has prescribed?
The first time this happens, you undoubtedly have many questions: Is there a difference between branded and generic medicines? Will the generic be just as safe and effective? Do insurance companies prefer generics? If you have, you’re not alone in asking these questions.
 It’s no secret that the rising costs of health care services and medications have been affecting millions of Americans – indeed, our economy – and will undoubtedly continue to do so in the future. However, generic alternatives have proven to be a critical factor in slowing down national health care spending. In fact, generic drug use has saved America’s health care system approximately $1.07 trillion over the past decade, with $192.8 billion in savings achieved in 2011 alone, according to a 2012 study by the IMS Institute for Healthcare Informatics.
However, while consumers recognize the cost advantage of generic drugs, they are reminded, from time to time, of the question of quality and efficacy of generic medications versus name-brand equivalents. Consumers should know that the U.S. Food and Drug Administration, the federal agency responsible for protecting and promoting public health, requires that generic drugs must be identical or “bioequivalent” to brand name drugs in dosage form, safety, strength, route of administration, quality, performance characteristics and intended use.
“The U.S. FDA tests generic medicines just as rigorously as their branded counterparts,” explains Venkat Krishnan, senior vice president and regional director at Ranbaxy Inc. “Generic drugs must meet rigid qualifying criteria before they can be made available to the general public. At Ranbaxy, we have stringent protocols in place to ensure that our products are both safe and effective, and we stand behind that, focused on our philosophy of ‘Quality and Patients First.’”
People are choosing generics in increasing numbers, out of economic necessity and because they are increasingly better informed.Of the 4 billion prescriptions written in 2011, nearly 80 percent were dispensed using generic versions of their brand name counterpart. With generics, consumers have the option of paying a price that is as much as 85 percent lower than name-brand drugs.
If you have questions about switching to a generic prescription, have a conversation with your doctor or pharmacist, or visit www.gphaonline.org for more information and the facts about generic drugs.
Share This Free article |
Comments
(0)
Comments-icon Post a Comment
No Comments Yet
Read More Local Features
Poll
Sponsored By:

ID02_18218308_web.jpg
slideshow
E470_17642865_web.jpg
slideshow
FHHB_18227527_web.jpg
slideshow
CUO9_1630484_web.jpg
slideshow
More Americans choosing generic drugs
by Brandpoint (ARA) Sponsored Content
Jun 19, 2013 | 154 views | 0 0 comments | 22 22 recommendations | email to a friend | print
(BPT) - Have you ever gone to fill a prescription and the pharmacist asks if you’d like the generic version of the medication, perhaps reminding you that it is at a considerable cost savings over the brand-named drug? Or you’re told that your insurance will only cover the generic equivalent of what your doctor has prescribed?
The first time this happens, you undoubtedly have many questions: Is there a difference between branded and generic medicines? Will the generic be just as safe and effective? Do insurance companies prefer generics? If you have, you’re not alone in asking these questions.
 It’s no secret that the rising costs of health care services and medications have been affecting millions of Americans – indeed, our economy – and will undoubtedly continue to do so in the future. However, generic alternatives have proven to be a critical factor in slowing down national health care spending. In fact, generic drug use has saved America’s health care system approximately $1.07 trillion over the past decade, with $192.8 billion in savings achieved in 2011 alone, according to a 2012 study by the IMS Institute for Healthcare Informatics.
However, while consumers recognize the cost advantage of generic drugs, they are reminded, from time to time, of the question of quality and efficacy of generic medications versus name-brand equivalents. Consumers should know that the U.S. Food and Drug Administration, the federal agency responsible for protecting and promoting public health, requires that generic drugs must be identical or “bioequivalent” to brand name drugs in dosage form, safety, strength, route of administration, quality, performance characteristics and intended use.
“The U.S. FDA tests generic medicines just as rigorously as their branded counterparts,” explains Venkat Krishnan, senior vice president and regional director at Ranbaxy Inc. “Generic drugs must meet rigid qualifying criteria before they can be made available to the general public. At Ranbaxy, we have stringent protocols in place to ensure that our products are both safe and effective, and we stand behind that, focused on our philosophy of ‘Quality and Patients First.’”
People are choosing generics in increasing numbers, out of economic necessity and because they are increasingly better informed.Of the 4 billion prescriptions written in 2011, nearly 80 percent were dispensed using generic versions of their brand name counterpart. With generics, consumers have the option of paying a price that is as much as 85 percent lower than name-brand drugs.
If you have questions about switching to a generic prescription, have a conversation with your doctor or pharmacist, or visit www.gphaonline.org for more information and the facts about generic drugs.
Share This Free article |
Comments
(0)
Comments-icon Post a Comment
No Comments Yet
View Previous Polls
Special Sections
ID02_18218308_web.jpg
slideshow
E470_17642865_web.jpg
slideshow
FHHB_18227527_web.jpg
slideshow
CUO9_1630484_web.jpg
slideshow
More Americans choosing generic drugs
by Brandpoint (ARA) Sponsored Content
Jun 19, 2013 | 154 views | 0 0 comments | 22 22 recommendations | email to a friend | print
(BPT) - Have you ever gone to fill a prescription and the pharmacist asks if you’d like the generic version of the medication, perhaps reminding you that it is at a considerable cost savings over the brand-named drug? Or you’re told that your insurance will only cover the generic equivalent of what your doctor has prescribed?
The first time this happens, you undoubtedly have many questions: Is there a difference between branded and generic medicines? Will the generic be just as safe and effective? Do insurance companies prefer generics? If you have, you’re not alone in asking these questions.
 It’s no secret that the rising costs of health care services and medications have been affecting millions of Americans – indeed, our economy – and will undoubtedly continue to do so in the future. However, generic alternatives have proven to be a critical factor in slowing down national health care spending. In fact, generic drug use has saved America’s health care system approximately $1.07 trillion over the past decade, with $192.8 billion in savings achieved in 2011 alone, according to a 2012 study by the IMS Institute for Healthcare Informatics.
However, while consumers recognize the cost advantage of generic drugs, they are reminded, from time to time, of the question of quality and efficacy of generic medications versus name-brand equivalents. Consumers should know that the U.S. Food and Drug Administration, the federal agency responsible for protecting and promoting public health, requires that generic drugs must be identical or “bioequivalent” to brand name drugs in dosage form, safety, strength, route of administration, quality, performance characteristics and intended use.
“The U.S. FDA tests generic medicines just as rigorously as their branded counterparts,” explains Venkat Krishnan, senior vice president and regional director at Ranbaxy Inc. “Generic drugs must meet rigid qualifying criteria before they can be made available to the general public. At Ranbaxy, we have stringent protocols in place to ensure that our products are both safe and effective, and we stand behind that, focused on our philosophy of ‘Quality and Patients First.’”
People are choosing generics in increasing numbers, out of economic necessity and because they are increasingly better informed.Of the 4 billion prescriptions written in 2011, nearly 80 percent were dispensed using generic versions of their brand name counterpart. With generics, consumers have the option of paying a price that is as much as 85 percent lower than name-brand drugs.
If you have questions about switching to a generic prescription, have a conversation with your doctor or pharmacist, or visit www.gphaonline.org for more information and the facts about generic drugs.
Share This Free article |
Comments
(0)
Comments-icon Post a Comment
No Comments Yet
ID02_18218308_web.jpg
slideshow
E470_17642865_web.jpg
slideshow
FHHB_18227527_web.jpg
slideshow
CUO9_1630484_web.jpg
slideshow
More Americans choosing generic drugs
by Brandpoint (ARA) Sponsored Content
Jun 19, 2013 | 154 views | 0 0 comments | 22 22 recommendations | email to a friend | print
(BPT) - Have you ever gone to fill a prescription and the pharmacist asks if you’d like the generic version of the medication, perhaps reminding you that it is at a considerable cost savings over the brand-named drug? Or you’re told that your insurance will only cover the generic equivalent of what your doctor has prescribed?
The first time this happens, you undoubtedly have many questions: Is there a difference between branded and generic medicines? Will the generic be just as safe and effective? Do insurance companies prefer generics? If you have, you’re not alone in asking these questions.
 It’s no secret that the rising costs of health care services and medications have been affecting millions of Americans – indeed, our economy – and will undoubtedly continue to do so in the future. However, generic alternatives have proven to be a critical factor in slowing down national health care spending. In fact, generic drug use has saved America’s health care system approximately $1.07 trillion over the past decade, with $192.8 billion in savings achieved in 2011 alone, according to a 2012 study by the IMS Institute for Healthcare Informatics.
However, while consumers recognize the cost advantage of generic drugs, they are reminded, from time to time, of the question of quality and efficacy of generic medications versus name-brand equivalents. Consumers should know that the U.S. Food and Drug Administration, the federal agency responsible for protecting and promoting public health, requires that generic drugs must be identical or “bioequivalent” to brand name drugs in dosage form, safety, strength, route of administration, quality, performance characteristics and intended use.
“The U.S. FDA tests generic medicines just as rigorously as their branded counterparts,” explains Venkat Krishnan, senior vice president and regional director at Ranbaxy Inc. “Generic drugs must meet rigid qualifying criteria before they can be made available to the general public. At Ranbaxy, we have stringent protocols in place to ensure that our products are both safe and effective, and we stand behind that, focused on our philosophy of ‘Quality and Patients First.’”
People are choosing generics in increasing numbers, out of economic necessity and because they are increasingly better informed.Of the 4 billion prescriptions written in 2011, nearly 80 percent were dispensed using generic versions of their brand name counterpart. With generics, consumers have the option of paying a price that is as much as 85 percent lower than name-brand drugs.
If you have questions about switching to a generic prescription, have a conversation with your doctor or pharmacist, or visit www.gphaonline.org for more information and the facts about generic drugs.
Share This Free article |
Comments
(0)
Comments-icon Post a Comment
No Comments Yet